Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD1901 in Postmenopausal Women With Vasomotor Symptoms
NCT02653417Phase 2Terminated
- Start
- Dec 2015
- Primary completion
- Dec 2016
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of elacestrant in vasomotor symptoms. Started Dec 2015; status: terminated.
02
Drugs
elacestrant
03
Conditions
vasomotor symptoms
Beyond the preview
Go deeper on NCT02653417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02653417.